Synthesis of Cyclopentane Monomers, SAMT-247, and Preclinical Studiesview on SAM.gov

General Information Document Type: Presolicitation Synopsis Number: 75N98026Q00735 Posted Date: July 2, 2026 Original Response Date: July 13, 2026 Current Response Date: July 13, 2026 Set Aside: N/A NAICS Code: 541715 Contracting Office Address National Institutes of Health (NIH), Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division 6701 Rockledge Drive Bethesda, MD 20817 Description INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: Frontage Laboratories, Inc. 700 Pennsylvania DR Exton, Pennsylvania 19341 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541715 with a Size Standard $1000. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION Title: Synthesis of Cyclopentane Monomers, SAMT-247, and Preclinical Studies Background Information: The mission of the National Institutes of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is to conduct and support biomedical research, research training, and the development of scientists, as well as to disseminate science-based research findings related to diabetes and metabolic diseases; digestive diseases and obesity; and infectious and immunologic diseases in order to improve people's health and quality of life. As part of its statutorily mandated functions, the NIDDK conducts and supports a broad range of biomedical research through both intramural research performed within NIH laboratories and extramural research supported through grants to universities and medical research institutions nationwide. In addition, the NIDDK supports research training programs for students and scientists at various stages of their careers and conducts education and outreach activities to provide science-based information to patients and their families, health ca…